标题
Atypical antipsychotic-induced mania: A systematic review and meta-analysis
作者
关键词
-
出版物
JOURNAL OF AFFECTIVE DISORDERS
Volume 333, Issue -, Pages 420-435
出版商
Elsevier BV
发表日期
2023-04-20
DOI
10.1016/j.jad.2023.04.037
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Functional neuroanatomy of mania
- (2022) Gonçalo Cotovio et al. Translational Psychiatry
- Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis
- (2021) Aditi Kadakia et al. BMC Psychiatry
- New Developments in the Use of Atypical Antipsychotics in the Treatment of Bipolar Disorder: a Systematic Review of Recent Randomized Controlled Trials
- (2021) Kamyar Keramatian et al. Current Psychiatry Reports
- Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study
- (2021) Teruhiko Higuchi et al. International Journal of Bipolar Disorders
- Evaluation of cariprazine in the treatment of bipolar I and II depression
- (2020) Lakshmi N. Yatham et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Hypomania in a depressed man following the introduction of brexpiprazole: A case report
- (2020) S. Lafrenière et al. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE
- Double‐blind , placebo‐controlled study of lurasidone monotherapy for the treatment of bipolar I depression
- (2020) Tadafumi Kato et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- The Early Burden of Disability in Individuals With Mood and Other Common Mental Disorders in Ontario, Canada
- (2020) Benicio N. Frey et al. JAMA Network Open
- Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study
- (2019) Willie Earley et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study
- (2019) Willie R. Earley et al. BIPOLAR DISORDERS
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
- (2018) Lakshmi N Yatham et al. BIPOLAR DISORDERS
- Real-world effectiveness and safety of aripiprazole augmentation therapy in patients with major depressive disorder
- (2018) Kunitoshi Kamijima et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment
- (2017) Somaia Mohamed et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Case Series Reports on Lurasidone-Associated Mania
- (2017) Louis A. Doan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study
- (2017) Melissa P. DelBello et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study
- (2016) Trisha Suppes et al. AMERICAN JOURNAL OF PSYCHIATRY
- An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression
- (2016) Suresh Durgam et al. AMERICAN JOURNAL OF PSYCHIATRY
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
- (2016) Sidney H. Kennedy et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY
- (2016) Terence A. Ketter et al. DEPRESSION AND ANXIETY
- Neuroprogression and illness trajectories in bipolar disorder
- (2016) Natália S Kapczinski et al. Expert Review of Neurotherapeutics
- Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts
- (2016) Trisha Suppes et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Bipolar disorder
- (2016) Iria Grande et al. LANCET
- Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial
- (2016) Huafang Li et al. PSYCHOPHARMACOLOGY
- Neuroprogression and illness trajectories in bipolar disorder
- (2016) Natália S Kapczinski et al. Expert Review of Neurotherapeutics
- Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis
- (2015) Xinyu Zhou et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Aripiprazole Adjunct Treatment in Bipolar I or II Disorder, Depressed State
- (2015) Rao N. Malempati JOURNAL OF NERVOUS AND MENTAL DISEASE
- Efficacy and Safety of Extended-Release Quetiapine Fumarate in Youth with Bipolar Depression: An 8 Week, Double-Blind, Placebo-Controlled Trial
- (2014) Robert L Findling et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study
- (2014) Man Wang et al. PSYCHOPHARMACOLOGY
- Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Antony Loebel et al. AMERICAN JOURNAL OF PSYCHIATRY
- Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Antony Loebel et al. AMERICAN JOURNAL OF PSYCHIATRY
- Low-Dose Manic Switch and High-Dose Antimanic Effect and Extrapyramidal Symptoms by Aripiprazole in a Single Bipolar Patient
- (2013) Young-Min Park AMERICAN JOURNAL OF THERAPEUTICS
- Update on Typical and Atypical Antipsychotic Drugs
- (2012) Herbert Y. Meltzer Annual Review of Medicine
- Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression
- (2012) Mauricio Tohen et al. BRITISH JOURNAL OF PSYCHIATRY
- Hypomania Associated With Adjunctive Aripiprazole in an Elder Female With Recurrent Major Depressive Disorder
- (2012) Hsiang-Yuan Lin et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
- (2011) Kathleen R. Merikangas et al. ARCHIVES OF GENERAL PSYCHIATRY
- Atypical antipsychotic-induced mania/hypomania: a review of recent case reports and clinical studies
- (2011) Amine Benyamina et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- The Neurobiology of the Switch Process in Bipolar Disorder
- (2010) Giacomo Salvadore et al. JOURNAL OF CLINICAL PSYCHIATRY
- Three Cases of Hypomania and One Case of Mania During Aripiprazole Treatment
- (2010) M. Viikki et al. PHARMACOPSYCHIATRY
- Functional Impairment and Disability across Mood States in Bipolar Disorder
- (2010) Adriane R. Rosa et al. VALUE IN HEALTH
- A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently
- (2009) Wayne Macfadden et al. BIPOLAR DISORDERS
- The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders
- (2009) Mauricio Tohen et al. BIPOLAR DISORDERS
- Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: results of an 8-week open label trial
- (2009) William V. Bobo et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression
- (2009) Trisha Suppes et al. JOURNAL OF AFFECTIVE DISORDERS
- Aripiprazole Monotherapy in Nonpsychotic Bipolar I Depression
- (2009) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started